CareDx Inc reports results for the quarter ended December 31 - Earnings Summary

• CareDx Inc CDNA.OQ reported quarterly adjusted earnings of 18 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -17 cents. The mean expectation of nine analysts for the quarter was for earnings of 13 cents per share. Wall Street expected results to range from 6 cents to 18 cents per share.

• Revenue rose 32% to $86.58 million from a year ago; analysts expected $84.12 million.

• CareDx Inc's reported EPS for the quarter was $1.51​.

• The company reported quarterly net income of $87.7 million.

• CareDx Inc shares had fallen by 2.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 148.8% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for CareDx Inc is $32.50

This summary was machine generated from LSEG data February 26 at 10:56 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)